Highly Leveraged Pharmaceuticals Companies

Total Debt
Total DebtEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
548.94 B
 0.00 
 1.38 
 0.00 
2NVO Novo Nordisk AS
102.79 B
(0.11)
 3.85 
(0.44)
3PFE Pfizer Inc
63.65 B
 0.07 
 1.47 
 0.11 
4BMY Bristol Myers Squibb
51.2 B
 0.00 
 1.92 
 0.00 
5RDY Dr Reddys Laboratories
46.77 B
 0.05 
 1.49 
 0.08 
6MRK Merck Company
37.11 B
 0.05 
 1.89 
 0.10 
7JNJ Johnson Johnson
36.63 B
 0.14 
 1.31 
 0.18 
8LLY Eli Lilly and
33.64 B
 0.03 
 1.92 
 0.05 
9NVS Novartis AG ADR
31.26 B
 0.09 
 1.30 
 0.12 
10AZN AstraZeneca PLC ADR
30.11 B
 0.11 
 1.58 
 0.18 
11BHC Bausch Health Companies
21.62 B
 0.15 
 2.92 
 0.43 
12TEVA Teva Pharma Industries
18.08 B
(0.08)
 2.43 
(0.20)
13SNY Sanofi ADR
17.91 B
(0.03)
 1.78 
(0.05)
14GSK GlaxoSmithKline PLC ADR
16.99 B
 0.03 
 1.80 
 0.06 
15VTRS Viatris
14.31 B
 0.01 
 1.97 
 0.02 
16OGN Organon Co
8.88 B
(0.02)
 3.05 
(0.07)
17RPRX Royalty Pharma Plc
7.61 B
 0.18 
 1.30 
 0.24 
18ZTS Zoetis Inc
6.74 B
(0.09)
 1.57 
(0.15)
19JAZZ Jazz Pharmaceuticals PLC
6.16 B
 0.15 
 1.65 
 0.24 
20ELAN Elanco Animal Health
4.32 B
 0.13 
 1.94 
 0.26 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively. In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.